deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL 1-arm NCT00910104

Cholestasis Reversal: Efficacy of IV Fish Oil (Reversal)

Sponsor: Mark Puder

Interventions Omegaven®
Updated 13 times since 2017 Last updated: Aug 19, 2024 Started: Aug 31, 2006 Primary completion: Jan 23, 2019 Completion: Jan 23, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Gastrointestinal Disease and Parenteral Nutrition Associated Liver Disease and is currently completed. Mark Puder leads this study, which shows 13 recorded versions since 2006 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Jul 2019 · 11 months · monthly snapshot~Jul 2019 – ~Sep 2020 · 14 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – present · 21 months · monthly snapshot

Change History

13 versions recorded
  1. Oct 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Sep 2024 — Oct 2024 [monthly]

    Completed PHASE2/PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  5. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

Show 8 earlier versions
  1. Jul 2019 — Sep 2020 [monthly]

    Completed PHASE2_PHASE3

    Status: RecruitingCompleted

  2. Aug 2018 — Jul 2019 [monthly]

    Recruiting PHASE2_PHASE3

  3. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE2_PHASE3

  4. Apr 2018 — Jun 2018 [monthly]

    Recruiting PHASE2_PHASE3

  5. Dec 2017 — Apr 2018 [monthly]

    Recruiting PHASE2_PHASE3

  6. Jun 2017 — Dec 2017 [monthly]

    Recruiting PHASE2_PHASE3

  7. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE2_PHASE3

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2_PHASE3

    First recorded

Aug 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Mark Puder
Data source: Boston Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations